Astrana targets $72.5M-$77.5M Q3 adjusted EBITDA while raising 2026 adjusted EBITDA to $255M-$280M
Astrana has set a target for adjusted EBITDA of $72.5 million to $77.5 million for the third quarter of 2026, while also raising its full-year adjusted EBITDA guidance for 2026 to $255 million to $280 million.
The current price is near a support level, indicating a potential entry point while confirming downside rigidity. Due to the extreme oversold condition with an RSI of 12.8, there is a possibility of a short-term technical rebound; however, the reliability is low, necessitating a conservative approach.
If the support level of $34.57 holds, I will aim to take profits with a target of $49.98. However, if the support level of $34.57 is breached, I will strictly adhere to my stop-loss criteria.
The RSI(14) is at 12.8, indicating an extreme oversold condition, with the moving averages in a positive alignment. The trading volume is 0.94 times the 20-day average, and the recent 7-day volatility is recorded at -6.2%.
At the time of the forecast, despite an extreme oversold condition with an RSI of 12.8, a conservative target return of 3.0% was set due to low confidence in a rebound. However, the actual result recorded a return of 10.5%, resulting in an OVERHIT designation. While the defense of downward rigidity near the support level and the positive impact of the upward guidance on short-term rebound momentum were accurately assessed, the overly low evaluation of the rebound strength in the oversold range remains a disappointment.
When extreme oversold indicators (RSI 12.8) coincide with positive earnings guidance upgrades, it is important to reflect this in the next trading decisions, as a stronger-than-expected trend reversal may occur even if the reliability of a technical rebound appears low. Therefore, we should allow for a bit more flexibility in setting the target price.